Senhwa Biosciences Senhwa Biosciences is a drug development company focused on next-generation DNA damage response therapeutics for the treatment of cancer. | ![]() Instil Bio Instil Bio (formerly Immetacyte, Cellular Therapeutics) is an immuno-oncology company that specializes in cell therapies. | Paragon Gene Therapy Paragon Gene Therapy is a company that focuses on transformative technologies, including gene therapies, vaccines, and oncology immunotherapies. | Strata Oncology Strata Oncology is a precision oncology company enabling molecular indications for cancer therapeutics. | Neogene Therapeutics Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer. | |
Founding Date | Founding Date 2012 | Founding Date 2008 | Founding Date 1990 | Founding Date 2016 | Founding Date 2018 |
Type | Type Public | Type Public | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Dallas, US HQ Dallas, US | Locations Baltimore, US HQ | Locations Ann Arbor, US HQ | Locations New York, US HQ Amsterdam, NL |
Employees | Employees N/A | Employees 1471% decrease | Employees 59 | Employees 32 | Employees 191 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 90m (almost 5 years ago) | Latest funding round $ 110m (over 5 years ago) |
Total funding raised | Total funding raised $ 17m | Total funding raised N/A | Total funding raised $ 20m | Total funding raised $ 128m | Total funding raised $ 110m |

Instil Bio (formerly Immetacyte, Cellular Therapeutics) is an immuno-oncology company that specializes in cell therapies.
View companyParagon Gene Therapy is a company that focuses on transformative technologies, including gene therapies, vaccines, and oncology immunotherapies.
View companyStrata Oncology is a precision oncology company enabling molecular indications for cancer therapeutics.
View companyNeogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer.
View company